Introduction
Being diagnosed with grave or alarming disease conditions could ruin not only their physical well-being but also their mental peacefulness. It has been perceived as an emotional rollercoaster for the entire family and their loved ones. Unpredictable outcomes, propensity for disease coming back again, survival prospects, emotional breakdown, financial burden, and everything pushes harder and makes the journey taxing and draining. Cancer is one such ailment that might be a grave shock and trauma for the patient as well as their family as it is globally perceived as a life-threatening state. It could put them through mental agony, unexplainable grief, and a sense of helplessness.
What Is Chronic Myeloid Leukemia?
Chronic myeloid leukemia (CML) is a discrete version of blood cancer (leukemia), where the cancerous changes are inflicted on a particular subset of blood-forming cells. Chronic myelogenous leukemia is another denomination for CML. Tiredness, bone pain, unreasonable and overstated weight loss, weakness, shortness of breath, fever, night sweats, and incapability to perform routine tasks are some manifestations brought out by chronic myeloid leukemia.
In CML, upon progression, the cancer cell proportions upscale tremendously, which eventually downturns the proportions of other blood cells, like platelets and red blood cells. Furthermore, the functional white blood cell proportion tones down with CML progression. Therefore, anemia (inflicted by diminished red blood cell proportion), overstated inclination for bleeding (bruising), and heightened propensity for frequent infections are also encountered in chronic myeloid leukemia owing to derangements in the functional red cell, platelets and white cell proportions. CML life expectancy with treatment is appreciable, underscoring the prognostic scope for CML.
Is Chronic Myeloid Leukemia Deadly?
Cancers are always tagged as deadly ailments, and so are chronic myeloid leukemia. However, the deadliness or graveness of the cancer is piloted by its severity and extent of progression. Early or initial staged cancer could be rooted out and eliminated completely. Still, it is not the same for advanced stages where complete de-rooting or extraction cannot be employed. With no medical support or interventions instituted, CML could be deadly and may delimit the life expectancy to another two or three years. Having said that, CML also expresses appreciable recovery prospects with prompt and timely medical assistance. The slow progressive attribute of CML augments and gears up the recovery and prognostic features, rendering enough time for disease recognition and employing therapeutic interventions to shut off CML progression and its eradication. However, it could be achieved only with targeted therapeutic strategies like tyrosine kinase inhibitors. Considering CML prognosis traits, more than 90 percent of CML patients within 60 years of age showcased life expectancy surpassing five years. In contrast, that for the senior population over 60 years is estimated to be 80 percent. Individuals with CML in the chronic phase will not express notable palliation in longevity, while those in the accelerated phase will have.
Is CML Curable?
Complete curation is challenging and often unattainable. However, with novel anti-cancer therapeutics, CML could potentially be tackled and restrained from heading into the advanced stage. Effective and constructive treatments for CML, like tyrosine kinase inhibitors (TKI), could downturn the expression of the susceptible gene that has instigated and prompted chronic myeloid leukemia. With TKI, many CML patients tend to attain remissions, during which the CML manifestations clear off, bringing out a symptom-free period. The diagnostic modalities do bring out negative results all through the remission period, underscoring the fact that chronic myeloid leukemia is suspended or settled for a specific duration. It could be protracted for years, and the anticancer therapeutics could also be withdrawn as advocated by the medical team. However, remission is not a complete cure and, therefore, necessitates meticulous scrutiny to pin down any recurrence.
How to Live with Chronic Myeloid Leukemia?
Living with chronic myeloid leukemia is quite taxing and distressing. Periods of remission could be drawn out with CML treatments like tyrosine kinase inhibitors; however, one ought to adhere to periodic reviews and interventional therapies to ease the journey and upscale the chronic myeloid leukemia survival rates. At times, the concerned doctor (hematologist or oncologist) may advocate for the withdrawal and suspension of the tyrosine kinase inhibitor therapy amidst the remission period; only then it can be halted.
Patients will take time to sink in and adjust to the truth of their disease. CML diagnosis will draw the person into a horrific and dreadful mental state. Deteriorated mental peace could further downturn the person’s health profile. Therefore, the person needs to be well informed of the recovery possibilities and augment their mental strength and hope. Medical assistance could be rendered to mitigate the anxiety and stress brought out by CML diagnosis. Stress management through proper awareness and mediation could be advocated for CML patients owing to its pertinence in rendering mental serenity and assurance.
Adherence to the treatment protocol devised and framed by the medical team is critical to ascertaining CML prognosis. Keeping track of the follow-ups and medication could expedite functional recovery and could gravitate the chronic myeloid leukemia survival rates. In order to ensure physical health and keep oneself energized to counter the ailment, ensure that the patient sticks to and engages with a healthy lifestyle. Physical activities also augment the CML patient’s physical and mental fitness.
While living with CML, one may encounter severe adverse events that are inflicted and drawn out by the anticancer therapies that the person has undergone or is living through. Therefore, another critical aspect to deal with is the side effects brought out by the interventional modalities. The side effect profile evidences variances in the types of therapeutic interventions that have been instituted. Chemotherapy (by employing high-dose drugs to mutilate leukemic cells) and TKI therapies have discrete side effect profiles. Chemotherapy has a greater inclination for side effects than TKIs. Any side effects that crop up in between ought to be reported so that the doctor can devise any proactive strategies to mitigate the side effects or the intricacies that it could bring out. Side effects often deteriorate and downturn the CML patient’s quality of life. So, by palliating the therapy invoked side effects, the quality of life could be upscaled and revived.
Conclusion
Living with chronic myeloid leukemia is not as simple as how it is elucidated in papers. CML patients have to cope with mental agony, protracted therapy, side effects (drawn out by the therapies), deteriorated quality of life, hampered professional and personal life, and uncertainty concerning their future. However, the medical provisions have evolved and emerged to alleviate and tone down the intricacies that crop up while living with chronic myeloid leukemia. Healthy lifestyle choices, adjusting to life on TKIs, and emotional support and stability alongside the therapeutic modalities ease and improve the patient’s life with CML, which underscores and gravitates to CML recovery.
